An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance - closely monitoring their cancer - rather than aggressive treatment to avoid the debilitating potential side effects ...
Dec 1, 2015
0
3
Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his post-treatment follow-up testing ...
Nov 2, 2015
0
7
In the wake of changing guidelines related to prostate cancer screening, a newly published review article out of University Hospitals Case Medical Center's Seidman Cancer Center in Cleveland provides important guidance about ...
Sep 17, 2015
0
12
Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers ...
Aug 31, 2015
0
64
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers ...
Jul 24, 2015
0
21
(HealthDay)—Many clinically low-risk prostate cancer patients are upgraded at prostatectomy, according to a study published in the August issue of The Journal of Urology.
Jul 20, 2015
0
25
After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/ watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with ...
Jul 7, 2015
0
4
(HealthDay)—A majority of U.S. men with low-risk prostate cancer who are eligible for active surveillance still undergo treatment, according to a new report published online June 29 in JAMA Internal Medicine.
Jul 1, 2015
0
8
An analysis of data on 945 patients with prostate cancer that is managed with active surveillance shows differences in outcomes depending on whether the patient was low or intermediate risk at diagnosis. Compared to patients ...
Feb 24, 2015
0
10
(HealthDay)—New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary.
Feb 19, 2015
0
8
